Related Experiment Video
Updated: Jun 4, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Influence of glycosylated hemoglobin on sight-threatening diabetic retinopathy: a population-based study
Rajiv Raman1, Aditya Verma, Swakshyar Saumya Pal
1Shri Bhagwan Mahavir Vitreoretinal Services, 18 College Road, Sankara Nethralaya, Chennai 600 006, Tamil Nadu, India.
Insights
Elevated glycosylated hemoglobin (HbA1c) levels above 8.0% are significantly linked to sight-threatening diabetic retinopathy (STDR). This finding is crucial for identifying individuals at high risk during diabetes screening programs.
Area of Science:
- Ophthalmology
- Endocrinology
- Public Health
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss globally.
- Glycosylated hemoglobin (HbA1c) is a key marker for long-term glycemic control in diabetes.
- Identifying individuals at risk for sight-threatening diabetic retinopathy (STDR) is critical for timely intervention.
Purpose of the Study:
- To investigate the association between HbA1c levels and the incidence of STDR in an urban Indian population.
- To determine a potential HbA1c threshold for identifying STDR risk in screening programs.
Main Methods:
- A cross-sectional study was conducted in Chennai, India, involving 1414 diabetic individuals.
- HbA1c levels were measured using liquid chromatography.
- Participants were categorized into no DR, non-STDR, and STDR groups based on fundus photography.
Main Results:
- Statistically significant differences in diabetes duration, BMI, HbA1c, and albuminuria were observed between groups.
- Multivariate analysis confirmed HbA1c as a significant predictor for both non-STDR (OR=1.23) and STDR (OR=1.31) compared to no DR.
- Receiver Operating Characteristic analysis suggested an HbA1c cut-off of 8.0% for STDR detection, with 75.6% sensitivity and 58.2% specificity.
Conclusions:
- An HbA1c level exceeding 8.0% is significantly associated with STDR.
- An HbA1c cut-off of 8.0% demonstrates potential utility in maximizing STDR detection within screening programs.
Aim:
To evaluate the role of glycosylated hemoglobin (HbA1c) on the occurrence of sight-threatening diabetic retinopathy (STDR) in urban Chennai, Tamil Nadu, India.
Methods:
A total of 5999 individuals were enumerated from the Chennai metropolis. Of these, 1414 subjects with diabetes were included for data analysis in the study. STDR or non-STDR groups were classified based on the fundus photographs. HbA1c was measured (Bio-Rad DiaSTAT™ HbA1c Reagent Kit) by the liquid chromatography technique.
Results:
A statistically significant difference (p < 0.05) was noted in the duration of diabetes, gender, body mass index, HbA1c, micro- and macro-albuminuria between both non-STDR and STDR groups as compared to the no-diabetic retinopathy (DR) group. On multivariate analysis, HbA1c (non-STDR: odd's ratio OR = 1.23; 95% confidence interval CI = 1.15-1.32; p < 0.0001; STDR: OR = 1.31 95% CI = 1.14-1.52; p < 0.0001) was found to be significantly associated with non-STDR and STDR when compared with the no-DR group. The Receiver Operating Characteristic analysis showed that the cut-off value of 8.0 had 75.6% sensitivity and 58.2% specificity with 64.9% maximum area under the curve.
Conclusion:
HbA1c value >8.0% was significantly related with STDR. In a screening programme, the cut-off value of HbA1c >8.0% provided a maximum yield of STDR.
Related Concept Videos
Diabetic Retinopathy
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Nephropathy
Diabetes Mellitus: Type 2 and Gestational
